|
|
 |
|
Viewing report
|
|
|
|
Novo Nordisk A/S - Strategy and SWOT Report
Datamonitor, Oct 2011, Pages: 49
Novo Nordisk A/S - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company.
Features:
- Detailed information on Novo Nordisk A/S required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Novo Nordisk A/S in the form of a SWOT analysis
- An in-depth view of the business model of Novo Nordisk A/S including a breakdown and examination of key business segments
- Intelligence on Novo Nordisk A/S’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Novo Nordisk A/S, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
Novo Nordisk is a healthcare company engaged in the manufacturing and marketing of diabetes products. It also offers product in the therapeutic areas of haemostasis management, growth hormone therapy and hormone replacement therapy. The company primarily operates in Europe, North America and Japan. It is headquartered in Bagsvaerd, Denmark and employed 30,483 people as of December 31, 2010. The company recorded revenues of DKK60,776 million ($10,824.2 million-) during the financial year (FY) ended December 2010, an increase of 19% over 2009. The operating profit of the company was DKK18,891 million ($3,364.5 million-) during FY2010, an increase of 26.5% over 2009. The net profit was DKK14,403 million ($2,565.2 million-) in FY2010, an increase of 33.8% over 2009. - Calculated using the constant conversion rate of DKK1 = $0.1781 for the financial year ended December 31, 2010.
Reasons to Purchase:
- Gain understanding of Novo Nordisk A/S and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Novo Nordisk A/S as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on Novo Nordisk A/S’s business structure, strategy and prospects
|
|
|
|
